Log in to the research portal to view current pricing, inventory, and bundles and place an order.
Shipping research peptides to Cheyenne
Research groups in Cheyenne receive third-party-tested vials with fast domestic dispatch. Peptides Factory Direct ships the full catalog to Cheyenne and across Wyoming; material arrives as a refrigerator-stable powder ready for reconstitution, and each Cheyenne lot carries a 99%+ purity target with a COA on request and a tracked lot number.
Research peptide categories shipped to Cheyenne
Cheyenne researchers can order across all seven research categories in the catalog. The table below maps each category to what it is studied for and example compounds.
| Research category | Studied for | Example research peptides |
|---|---|---|
| Healing & Recovery | Peptides studied for tissue repair, inflammation, and recovery. | BPC-157, TB-500, KPV |
| Growth Hormone & Muscle | GH-secretagogue and anabolic research peptides. | CJC-1295, Ipamorelin, GHRP-6 |
| Fat Loss & Weight Management | GLP-1/GIP and lipolysis research peptides. | Semaglutide, Tirzepatide, AOD 9604 |
| Anti-Aging & Longevity | Telomere, immune, and cellular-aging research peptides. | Epithalon, Thymosin Alpha-1 |
| Cognitive & Neurological | Nootropic and neuroprotection research peptides. | Selank, Semax, Cerebrolysin |
| Sexual Health & Tanning | Melanocortin-pathway research peptides. | PT-141, Melanotan II, Melanotan I |
| Specialty | Hormone, sleep, and condition-specific research peptides. | Gonadorelin, HCG, DSIP |
Research peptides Cheyenne researchers request most
Below are the research peptides Cheyenne laboratories most often order. Each summary reflects the published research literature and is provided for laboratory context only, and every compound is research-use-only and is not for human or animal consumption.
Tesamorelin (GHRH analog) research
Tesamorelin is a stabilized analog of growth-hormone-releasing hormone studied for its reported effect on visceral adipose tissue - the fat surrounding internal organs - in metabolic research models.
Research mechanism. Tesamorelin stimulates endogenous GH release like other GHRH analogs, with research focused specifically on visceral-fat endpoints rather than subcutaneous fat.
Visceral-fat research. Studied specifically for visceral adipose tissue endpoints.
Metabolic-health models. Examined for broader metabolic-syndrome research variables.
GHRH-axis research. Used as a GHRH analog in GH-release studies.
How it compares. Tesamorelin is studied for visceral fat specifically, distinguishing it from AOD 9604 (general lipolysis) and the GLP-1 peptides (appetite).
Research pairings. Studied as a standalone GHRH analog in metabolic research.
Reference research values. Research references commonly cite 1-2 mg daily. Reference values only.
Full Tesamorelin research profile → · Fat Loss & Weight Management peptides
DSIP (Delta Sleep-Inducing Peptide) research
DSIP (delta sleep-inducing peptide) is a naturally occurring neuropeptide studied for its reported association with delta-wave sleep and stress regulation. The research literature is mixed, which makes it an active area of investigation.
Research mechanism. DSIP research examines its role in sleep architecture, stress-hormone modulation, and pain endpoints, though the exact mechanism remains a research question.
Sleep research. Studied for sleep-quality and delta-wave endpoints in models.
Stress-regulation research. Examined for stress-hormone modulation.
Pain-modulation research. Used in exploratory pain-endpoint designs.
How it compares. DSIP is studied specifically for sleep and stress endpoints, distinct from the hormone and cognitive peptides.
Research pairings. Generally studied as a standalone sleep-research peptide.
Reference research values. Research references commonly cite 100-300 mcg before rest periods, used as-needed. Reference values only.
Full DSIP research profile → · Specialty peptides
Dihexa (high-potency nootropic) research
Dihexa is a synthetic peptide derived from angiotensin IV, studied for its reported high potency in promoting synaptic connections (synaptogenesis). The literature describes it as extremely potent relative to BDNF in model systems, with limited human data.
Research mechanism. Dihexa research focuses on the hepatocyte-growth-factor / c-Met system and synaptogenesis, with interest in memory and cognition endpoints.
Synaptogenesis research. Studied for formation of new synaptic connections in models.
Memory and cognition research. Examined for learning and memory endpoints.
Neurodegeneration models. Used in exploratory neurodegeneration research.
How it compares. Dihexa is studied as far more potent than Semax/Selank in model systems but with much less data, making it a specialized research tool.
Research pairings. Generally studied as a standalone high-potency nootropic.
Reference research values. Research references commonly cite 5-10 mg daily in 4-8 week cycled windows. Reference values only - an advanced compound with limited data; use caution.
Full Dihexa research profile → · Cognitive & Neurological peptides
Semax (BDNF nootropic) research
Semax is a synthetic heptapeptide derived from a fragment of adrenocorticotropic hormone (ACTH 4-10), developed in Russia. It is studied for cognitive and neuroprotective endpoints and is one of the most-cited nootropic research peptides.
Research mechanism. Semax research focuses on up-regulation of BDNF and nerve-growth-factor signaling and on modulation of monoamine systems, with interest in learning, memory, and neuroprotection endpoints.
Cognitive / focus research. Studied for attention, learning, and memory endpoints.
Neuroprotection research. Examined in models of neural stress and recovery.
BDNF-signaling research. A model compound for neurotrophic-factor studies.
How it compares. Semax is studied more for focus and BDNF, Selank more for anxiety; N-Acetyl Semax Amidate is a more potent, longer-lasting analog.
Research pairings. Semax + Selank pairs focus and anxiety endpoints in cognitive research.
Reference research values. Research references commonly cite 300-600 mcg daily across 2-4 week cycles. Reference values only.
Full Semax research profile → · Cognitive & Neurological peptides
Melanotan I (Afamelanotide) research
Melanotan I (afamelanotide) is a linear analog of alpha-MSH that is more selective than Melanotan II, studied for melanogenesis endpoints with fewer of the off-target effects reported for MT-II.
Research mechanism. Melanotan I research focuses on MC1R-mediated melanin synthesis, the pathway central to pigmentation research, with a more selective profile than the non-selective MT-II.
Pigmentation research. Studied for melanogenesis endpoints with a selective profile.
Photoprotection research. Examined in models of UV response.
Melanocortin-receptor research. A more selective MC1R model compound.
How it compares. Melanotan I is more selective and reportedly better tolerated in models than Melanotan II, with a narrower pigmentation focus.
Research pairings. Generally studied as a standalone selective melanocortin agonist.
Reference research values. Research references commonly cite a loading figure of 0.5-1 mg daily followed by 2-3 times weekly maintenance. Reference values only.
Full Melanotan I research profile → · Sexual Health & Tanning peptides
BPC-157 (Body Protection Compound 157) research
BPC-157 (Body Protection Compound 157) is a synthetic, stable pentadecapeptide of 15 amino acids derived from a partial sequence of a protein found in human gastric juice. In the research literature it is one of the most frequently studied "body protection" peptides because of its stability in gastric and aqueous environments and its broad activity across connective and epithelial tissue models.
Research mechanism. Research models associate BPC-157 with up-regulation of growth-factor signaling (notably the VEGFR2 pathway and FAK-paxillin signaling) that supports angiogenesis - the formation of new blood vessels - in injured tissue. It is also studied for modulation of the nitric-oxide system and for interaction with the gut-brain axis. These mechanisms are the subject of ongoing pre-clinical investigation and are reported in animal and in-vitro studies, not approved clinical indications.
Tendon and ligament repair research. A large share of BPC-157 literature examines tendon-to-bone healing, ligament models, and the tensile recovery of connective tissue after controlled injury. Researchers study it both locally (near a modeled injury site) and systemically because of its reported stability.
Gastrointestinal models. Because the parent sequence originates in gastric juice, BPC-157 is heavily studied in models of gut-lining integrity, ulceration, and inflammatory bowel conditions, where angiogenesis and epithelial repair are the variables of interest.
Inflammation and joint research. Anti-inflammatory signaling and joint-tissue models are a third common research theme, frequently paired with TB-500 in comparative stacking studies.
How it compares. Compared with TB-500, BPC-157 is studied as a faster-acting, more localized repair peptide; compared with GHK-Cu it targets connective and gut tissue rather than skin and hair. It is one of the most stability-tested peptides in the research catalog.
Research pairings. In the literature BPC-157 is most often studied alongside TB-500 (Thymosin Beta-4) for connective-tissue work, since the two are reported to act through complementary repair pathways - BPC-157 more locally and TB-500 through deeper, slower regeneration.
Reference research values. Research-reference protocols in the literature commonly cite 250-500 mcg once or twice daily over a 4-12 week study window, with some maintenance models at 250 mcg daily. These figures are reference values from published research only and are not dosing instructions for any living subject.
Full BPC-157 research profile → · Healing & Recovery peptides
GHRP-6 (Growth Hormone Releasing Peptide-6) research
GHRP-6 is a hexapeptide and one of the original growth-hormone-releasing peptides. In research it is notable for a strong reported effect on appetite signaling (via ghrelin-receptor activity) in addition to GH release.
Research mechanism. GHRP-6 activates the GH-secretagogue receptor to drive GH pulses and is studied for its pronounced hunger-signaling response, a useful variable in appetite-and-metabolism research.
GH-release research. A potent classic GHRP for growth-hormone-pulse studies.
Appetite-signaling research. Studied where the ghrelin/hunger axis is the variable of interest.
Recovery and tissue models. Examined for downstream recovery endpoints.
How it compares. Compared with Ipamorelin it produces stronger appetite signaling and GH release but with more off-target hormonal activity; GHRP-2 sits between the two.
Research pairings. GHRP-6 is sometimes studied with a GHRH analog like CJC-1295; researchers monitor prolactin in models.
Reference research values. Research references commonly cite 100-300 mcg two to three times daily. Reference values only.
Full GHRP-6 research profile → · Growth Hormone & Muscle peptides
Melanotan II (MT-II) research
Melanotan II is a synthetic analog of alpha-melanocyte-stimulating hormone, a non-selective melanocortin agonist. It is studied for melanogenesis (pigmentation) and broader melanocortin endpoints in research models.
Research mechanism. Melanotan II activates multiple melanocortin receptors, driving melanin production in research models and engaging MC4R pathways relevant to appetite and libido endpoints.
Pigmentation research. Studied for melanogenesis and tanning endpoints in models.
Melanocortin-pathway research. A broad melanocortin agonist for receptor studies.
Appetite/libido signaling research. Examined for MC4R-mediated endpoints.
How it compares. Melanotan II is a non-selective agonist studied for pigmentation and broad melanocortin endpoints; Melanotan I (afamelanotide) is more selective; PT-141 is studied for sexual function.
Research pairings. Generally studied as a standalone melanocortin agonist.
Reference research values. Research references commonly cite 0.5-1 mg two to three times weekly. Reference values only.
Full Melanotan II research profile → · Sexual Health & Tanning peptides
GHRP-2 (Growth Hormone Releasing Peptide-2) research
GHRP-2 is a synthetic hexapeptide growth-hormone secretagogue, studied as a middle ground between GHRP-6 (strong appetite signaling) and Ipamorelin (selective and clean).
Research mechanism. GHRP-2 activates the GH-secretagogue receptor for GH release, with a reportedly smaller appetite response than GHRP-6 and somewhat more than Ipamorelin in research models.
GH-release research. A potent GHRP for growth-hormone-pulse studies.
Body-composition models. Studied for downstream metabolic endpoints.
GHRH synergy research. Paired with CJC-1295 in stacking studies.
How it compares. GHRP-2 is studied as a balance between GHRP-6 potency/appetite and Ipamorelin selectivity.
Research pairings. GHRP-2 + CJC-1295 is a common research pairing; prolactin is monitored in models.
Reference research values. Research references commonly cite 100-300 mcg two to three times daily. Reference values only.
Full GHRP-2 research profile → · Growth Hormone & Muscle peptides
Tirzepatide (dual GLP-1/GIP agonist) research
Tirzepatide is a dual agonist that activates both GLP-1 and GIP (glucose-dependent insulinotropic polypeptide) receptors. It is one of the most-studied modern metabolic research peptides because it engages two incretin pathways at once.
Research mechanism. Tirzepatide research examines combined GLP-1 and GIP signaling on insulin response, satiety, and energy handling, with the dual-pathway mechanism the central research distinction.
Weight-management research. Studied for body-weight endpoints via dual incretin signaling.
Glucose-metabolism research. Examined for combined GLP-1/GIP metabolic effects.
Comparative incretin studies. Frequently compared with semaglutide.
How it compares. Tirzepatide adds GIP activity on top of GLP-1, which is the defining contrast with single-pathway semaglutide in research.
Research pairings. Studied as a standalone dual-agonist model or compared with semaglutide.
Reference research values. Research references describe a titration model from 2.5 mg up to 15 mg weekly over several weeks. Reference values only.
Full Tirzepatide research profile → · Fat Loss & Weight Management peptides
CJC-1295 (with or without DAC) research
CJC-1295 is a synthetic analog of growth-hormone-releasing hormone (GHRH). It is studied in two forms: "no DAC" (also called Mod GRF 1-29), which is short-acting, and "with DAC" (Drug Affinity Complex), which binds albumin for a markedly longer half-life in research models.
Research mechanism. CJC-1295 research focuses on stimulation of the pituitary to release growth hormone in pulses. The DAC version extends the active window, while the no-DAC version produces a sharper, shorter pulse often studied alongside a GHRP such as Ipamorelin for synergistic release.
Growth-hormone release research. The central research theme is endogenous GH-pulse stimulation and the comparison of DAC vs no-DAC kinetics.
Body-composition models. It is studied for downstream effects on muscle and fat metabolism in research models.
GHRH + GHRP synergy studies. CJC-1295 + Ipamorelin is one of the most-studied research pairings for amplified GH pulses.
How it compares. The DAC form trades fewer administrations for a longer, flatter profile; the no-DAC form is studied for sharper, more physiologic pulses. Choice depends on the research kinetics of interest.
Research pairings. CJC-1295 (no DAC) + Ipamorelin is the canonical research pairing; the GHRH analog and the GHRP are reported to act through complementary receptors.
Reference research values. Research references commonly cite 200-300 mcg of the no-DAC form before rest periods on a 5-7 day schedule, or 1-2 mg of the DAC form one to two times weekly. Reference values only.
Full CJC-1295 research profile → · Growth Hormone & Muscle peptides
HCG (Human Chorionic Gonadotropin) research
HCG (human chorionic gonadotropin) is a glycoprotein hormone that mimics luteinizing hormone. It has a well-established research profile and is studied for its downstream effects on gonadal hormone production.
Research mechanism. HCG research focuses on LH-receptor activation, stimulating gonadal tissue in research models - the downstream counterpart to upstream GnRH and Kisspeptin signaling.
Reproductive-hormone research. Studied for gonadal-hormone and fertility endpoints.
LH-analog research. A model compound for LH-receptor studies.
Hormone-axis research. Examined in models of endogenous hormone support.
How it compares. HCG mimics LH downstream, while Gonadorelin and Kisspeptin act upstream in the same axis.
Research pairings. Studied alongside GnRH peptides in hormone-axis research designs. Banned by WADA - relevant for sports-science researchers.
Reference research values. Research references commonly cite 250-500 IU two to three times weekly. Reference values only.
Full HCG research profile → · Specialty peptides
Ovagen (Organ Bioregulator) research
Ovagen is a peptide bioregulator from the Khavinson family, studied for reproductive and organ tissue-support concepts in research models. Peptide bioregulators are investigated for tissue-specific normalization of gene expression and protein synthesis.
Research mechanism. Ovagen research centers on tissue-specific peptide bioregulation - the concept that short peptides can support normal function and protein synthesis in their target organ tissue - within reproductive and organ-support research models.
Reproductive-tissue research. Studied for reproductive and organ tissue-support endpoints in models.
Organ-support research. Examined in bioregulator research focused on tissue normalization concepts.
Longevity bioregulator research. Investigated within the broader Khavinson bioregulator research framework.
How it compares. Ovagen is an organ/reproductive-tissue bioregulator, distinct from the vascular bioregulator Vesugen and the neuro bioregulator Pinealon.
Research pairings. Studied alongside other Khavinson bioregulators (Epithalon, Vesugen, Pinealon) in organ-support research designs.
Reference research values. Research references commonly cite 2-5 mg daily in short-course bioregulator study cycles. Reference values only - not for human or animal use.
Full Ovagen research profile → · Specialty peptides
Selank (anxiolytic nootropic) research
Selank is a synthetic heptapeptide derived from the immunomodulatory peptide tuftsin, developed in Russia. It is studied for anxiolytic (anti-anxiety) and cognitive endpoints without the sedation associated with classic anxiolytics.
Research mechanism. Selank research focuses on modulation of GABAergic and monoamine signaling and on brain-derived neurotrophic factor (BDNF) expression, with interest in anxiety and focus endpoints.
Anxiolytic research. Studied for anxiety endpoints without sedation in models.
Cognitive / focus research. Examined for attention and mental-clarity variables.
Neuroprotection and immune research. Its tuftsin lineage links it to immune-signaling studies.
How it compares. Selank is studied for anxiety endpoints where Semax is studied more for focus and BDNF; the two are complementary in cognitive research.
Research pairings. Selank + Semax is a common cognitive-research pairing (anxiety plus focus endpoints).
Reference research values. Research references commonly cite 250-500 mcg daily across 2-4 week cycles. Reference values only.
Full Selank research profile → · Cognitive & Neurological peptides
Research applications studied in Cheyenne
- Visceral-fat research (Tesamorelin). Studied specifically for visceral adipose tissue endpoints.
- Sleep research (DSIP). Studied for sleep-quality and delta-wave endpoints in models.
- Synaptogenesis research (Dihexa). Studied for formation of new synaptic connections in models.
- Cognitive / focus research (Semax). Studied for attention, learning, and memory endpoints.
- Pigmentation research (Melanotan I). Studied for melanogenesis endpoints with a selective profile.
How Cheyenne researchers order and store material
Ordering for a Cheyenne lab is done in the Peptides Factory Direct portal, with one-time or recurring options and a checkout confirmation of laboratory research use. Material ships to Cheyenne as a lyophilized powder for refrigerated storage; after reconstitution keep it cold and use within the standard research window. Cheyenne researchers remain responsible for compliance with applicable law, and nothing supplied is for human or animal consumption. Open the order portal.
Why Cheyenne researchers choose Peptides Factory Direct
Serious research material is judged on verifiable purity, not marketing. Peptides Factory Direct ships every Cheyenne order with a 99%+ purity target, a Certificate of Analysis on request, lot tracking, and reference research documentation for every compound in the catalog. Fast domestic dispatch means Cheyenne labs receive stable vials quickly.
Nearby Wyoming research areas we ship to
Frequently asked questions
Do you ship research peptides to Cheyenne, WY?
Yes. Peptides Factory Direct ships third-party-tested research peptides to Cheyenne and the surrounding Wyoming area with fast domestic delivery. Research use only.
How fast is delivery to Cheyenne?
Orders ship promptly as stable lyophilized vials; most Cheyenne deliveries arrive within standard domestic transit times. A Certificate of Analysis is available on request.
Is a COA available for Cheyenne research orders?
Yes - every lot shipped to Cheyenne is third-party tested to a 99%+ purity target with a Certificate of Analysis available on request.
Are research peptides legal to buy in Cheyenne, WY?
Research chemicals are generally legal to purchase for laboratory research in the US. Buyers in Cheyenne are responsible for compliance with local law; products are research-use-only and not for human or animal consumption.
Do you ship the full catalog to Cheyenne, or a limited list?
The full Peptides Factory Direct catalog of 33 research peptides ships to Cheyenne and the rest of Wyoming. There is no reduced regional list; Cheyenne researchers have the same selection as any US research address.
All Wyoming cities · All states · Research guides
External references: Wyoming (Wikipedia) · U.S. Census Bureau